Pharma blockbusters, pandemic policy, & legal chicanery
Is the next Lipitor on the way? When is a pandemic over-over? And what’s a Texas two-step? All that and more on the new episode of “The Readout LOUD” #podcast.
Is the next Lipitor on the way? When is a pandemic over-over? And what’s a Texas two-step? All that and more on the new episode of “The Readout LOUD” #podcast.
Health economist Ben Handel dissects UnitedHealth CEO Andrew Witty’s Senate testimony on the the Change Healthcare cyberattack.
Whether or not the USPSTF says “B” or “C,” the goal is for women in their 40s to have informative conversations with their health care…
Novo Nordisk on Thursday defended the prices of its blockbuster diabetes and obesity drugs Ozempic and Wegovy amid a Senate probe into what the company…
Measures of biological age have exploded into health research and have fueled hype around consumer tests. But the field of aging has still not settled…
In a rare observed case of self-treatment in a wild animal, scientists documented an orangutan applying a medicinal plant to a wound on his face.
Subscribe to STAT+ and stay up-to-date on the latest trends and ground breaking discoveries in cancer research.
Today’s biotech news updates include Novo Nordisk strong sales, bird flu in milk, and Novartis’ radiopharma plans
It’s widely known that exercise is beneficial for health — but why? A new study in rats offers insight.
Check out the latest edition of Adam’s Biotech Scorecard, a new newsletter from @statnews.
Extensive testing of pasteurized commercially purchased milk and other dairy products from 38 states found no evidence of live H5N1 bird flu virus.